To the editor:

Since early April 2009, the world has been responding to a pandemic of a novel H1N1 influenza A virus (pH1N1). Data on transmission and severity of pH1N1, especially from the Southern Hemisphere will help plan for the upcoming Northern Hemisphere influenza season. In mid‐June 2009, the Naval Medical Research Center Detachment in Peru, the CDC and the Peruvian Ministry of Health implemented a prospective cohort population‐based study of influenza in Peru. We report the first 6 weeks of this population‐based data, specifically describing the evolution and clinical data of pH1N1. 343 households from San Juan de Miraflores District, Lima and their household members were randomly selected from a previous census list using a computer‐based, randomly generated numbers table and invited to participate in the study. Subsequently, field workers performed screening visits to households three times per week to identify influenza‐like illness (ILI) cases. The ILI case definition for individuals ≥5 years of age included sudden onset of fever \>38°C, with cough and/or sore throat and for children \<5 years old, we utilized the WHO‐ILI case[^1^](#b1){ref-type="ref"} definition with the addition of rhinorrhea and/or nasal congestion. Once an ILI case was identified, both nasal and oropharyngeal swabs were collected, combined and placed into viral transport media, transported at 4°C to the laboratory and stored at −80°C. For each identified ILI case, multiple follow‐up site visits were conducted over a 15‐day period to determine clinical symptoms duration. Identification of pH1N1 was conducted using the CDC 2009 pH1N1 real‐time PCR (rRT‐PCR) assay,[^2^](#b2){ref-type="ref"} while seasonal influenza A viruses were identified using standard rRT‐PCR procedures. Attack rates (AR) and incidence rates (IR) were estimated by age group for ILI and pH1N1 confirmed cases.

A total of 1747 individuals, living in 343 households, were enrolled in the study from May to June, 2009. Screening visits were initiated on June 25, 2009 and, as of August 1, 191 ILI cases had been identified.

Of the 191 ILI cases, 134 were positive (70·1%) for pH1N1 -- only one seasonal H3N2 isolate was identified from samples negative for pH1N1. The percentage of ILI due to pH1N1 was highest in the age group of 5--17 years (86·2%) compared with other age groups ([Table 1](#t1){ref-type="table-wrap"}). The most common symptoms at illness onset among pH1N1 cases of all ages were cough (92·5%), rhinorrhea (77·6%), malaise (69·4%), sore throat (67·9%) followed by headache (64·9%), red eyes (47·8%), vomiting (25·4%), and diarrhea (9·7%). Median symptom duration among all pH1N1 cases that completed 15 days of follow‐up was cough 8 days (range 0--15 days), rhinorrhea 5 days (range 0--15 days), sore throat 2 days (range 0--12 days), fever 1 day (range 1--8 days), and headache 1 day (range 0--15 days). As of August 1 2009, the cumulative attack rate for confirmed pH1N1 infection among all ages was 7·7%. Age adjusted IRs of pH1N1 were slightly higher among young adults and children ([Table 1](#t1){ref-type="table-wrap"}) and were equivalent with respect to gender (data not shown), although few confirmed cases were identified among adults \>50 years of age. Weekly incidence rates of pH1N1 ranged from 11·7 to 27·8 cases/1000 person‐weeks. We have begun to observe a reduction of pH1N1 IRs and ARs, as well as a reduction in ILI ARs over time ([Table 1](#t1){ref-type="table-wrap"}). By extrapolating from our population‐based data for pH1N1 (AR = 7·7%), we estimate that 3800 pH1N1 cases may have occurred among individuals in the study population and \>300 000 cases among the population of Lima.

###### 

 Influenza‐like illness (ILIs) and pandemic H1N1 influenza (pH1N1) attack rates and incidence rates between June 14th and August 1st, 2009

  Dates           Epi weeks   ILIs total (*N* = 191)   pH1N1 (*N* = 134)   Other etiologies (*N* = 57)^†^   No of pH1N1/ ILIs (%)   pH1N1 cumulative attack rate (%)   Other etiologies cumulative attack rate (%)   Weekly pH1N1 incidence rate × 1000   Age specific weekly pH1N1 incidence rate × 1000                                         
  --------------- ----------- ------------------------ ------------------- -------------------------------- ----------------------- ---------------------------------- --------------------------------------------- ------------------------------------ ------------------------------------------------- ------- ------- ------- ------ ------ ------
  Jun 14--20      Week 24     1                        0                   1                                 0·00                   0·00                               0·06                                           0·00                                 0·00                                              0·00    0·00    0·00   0·00   0·00   0·00
  Jun 21--27      Week 25     29                       20                  9                                68·97                   1·15                               0·57                                          11·45                                 5·10                                             50      28·57    2·09   0·00   7·52   0·00
  Jun 28--Jul 4   Week 26     60                       47                  13                               78·33                   3·84                               1·32                                          27·23                                51·28                                             85·53   49·02   12·58   7·46   0·00   0·00
  Jul 5--11       Week 27     54                       39                  15                               72·22                   6·07                               2·18                                          23·23                                48·65                                             71·94   27·49   23·35   2·51   0·00   0·00
  Jul 12--18\*    Week 28     29                       19                  10                               65·52                   7·16                               2·75                                          11·59                                22·73                                             46·51   10·60    8·70   5·03   0·00   0·00
  Jul 19--25      Week 29     12                       6                   6                                50·00                   7·50                               3·09                                           3·70                                 5·81                                              8·13    7·14    2·19   0·00   7·58   0·00
  Jul 26--Aug 1   Week 30     6                        3                   3                                50·00                   7·67                               3·26                                           1·86                                 5·85                                              0·00    0·00    4·40   0·00   0·00   0·00

\*School closing from July 15th to August 9th

†All tested for influenza A and B, one H3N2 identified

These data provide the first unbiased description of the epidemiology of pH1N1 from a developing country as compared with national surveillance data, as they are gathered from an active population‐based surveillance system. Incidence rates within the Lima population cohort clearly demonstrate that the epidemic of pH1N1 was well established in the greater population of Lima at the time of the study screening. Cumulative ARs of pH1N1 (7·7%) have been very similar to those reported from southern hemisphere countries, such as New Zealand (7·5%).[^3^](#b3){ref-type="ref"} Furthermore, as with other countries, the ARs initially increased over time; however, these rates (both ILI and pH1N1) began to plateau during epidemiological weeks 29 and 30 ([Table 1](#t1){ref-type="table-wrap"}). As with other countries, pH1N1 IRs and ARs were highest in children \<18 years old. This may suggest that children are either more susceptible to infection with pH1N1, as compared with adults, or perhaps that their social network and/or behavior contributed to a higher risk of infection. As others have speculated, perhaps older populations, including those of Lima, have a partial protection to this novel strain.[^4^](#b4){ref-type="ref"} Follow‐up serological surveys may help clarify these findings. Our data demonstrate that the clinical symptoms and duration for pH1N1 infection are similar to what has been described for normal seasonal influenza illness.[^5^](#b5){ref-type="ref"} In slight contrast to the findings of Dawood *et al*, [^6^](#b6){ref-type="ref"} we identified a lower proportion of diarrhea among pH1N1 confirmed cases (9·7% vs. 25%).

Mitigation strategies, such as educational campaigns and airport screening of incoming foreign passengers, and discouraging mass gatherings, were implemented in mid‐April in Lima. Although these sorts of efforts have been shown to be useful in minimizing dissemination of influenza in other countries, and likely did so in Peru, these initial strategies did not prevent the spread of pH1N1 among the general population of Lima. Conversely, school closures may have helped to reduce the IRs and ARs of pH1N1 and ILI, respectively, among school aged children; however, it is also possible that school closures may have been implemented after most children had been ill, as rates in this population were already beginning to decline ([Figure 1 and Table 1](#f1){ref-type="fig"}, [\[link\]](#t1){ref-type="table-wrap"}). Additional weeks of surveillance and further studies (i.e., serological surveys) will help to address these questions. Alternatively, our results may reflect the early phase of this pandemic in Peru, with rapid transmission among children and young adults related to school contact and social behavior, with delayed spread among older adults.[^7^](#b7){ref-type="ref"}

![ pH1N1 Epidemiological curve between June 14th and August 1st 2009 in Lima, Peru.](IRV-3-253-g001){#f1}

Many investigators have suggested that 11--35% of outpatient ILI cases, globally, are due to seasonal influenza A and B viruses.[^8^](#b8){ref-type="ref"}, [^9^](#b9){ref-type="ref"}, [^10^](#b10){ref-type="ref"} As a result, one important question that arises is whether or not pH1N1 will displace seasonal influenza viral strains. Although our data are limited by short time period, most ILI cases had laboratory‐confirmed pH1N1 during the typical winter influenza season in Lima, 70·1% in total, with very little seasonal influenza virus circulation within this population. As mentioned previously, individuals \<18 years of age in our population had the highest proportion of pH1N1 as an etiologic agent of ILI (86·2%), opposed to what is normally observed in a prepandemic influenza season, whereby in this age group influenza virus is not the most common cause of respiratory illness.[^11^](#b11){ref-type="ref"}, [^12^](#b12){ref-type="ref"} These data may suggest a trend in displacement of seasonal influenza by pH1N1 as has been observed in other countries, including those in the Southern Hemisphere,[^13^](#b13){ref-type="ref"}, [^14^](#b14){ref-type="ref"} during this same period of time.[^15^](#b15){ref-type="ref"} Additional weeks of surveillance will help to clarify this finding.

Epidemiologic data on the impact of pandemic influenza from the Southern Hemisphere winter may help inform planning for the upcoming Northern Hemisphere influenza season. Data generated by this population‐based study has allowed calculation of measures of disease impact for a larger population. Such data may help inform pH1N1 mitigation strategies, surveillance strategies, and vaccine policy.
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